Giuseppe Campagnuolo
Amgen (United States)(US)
Publications by Year
Research Areas
Bone Metabolism and Diseases, Bone health and treatments, Pharmacological Effects of Medicinal Plants, Rheumatoid Arthritis Research and Therapies, Osteoarthritis Treatment and Mechanisms
Most-Cited Works
- → Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand(1999)1,862 cited
- → Anti-interleukin-1 and anti-tumor necrosis factor-α synergistically inhibit adjuvant arthritis in Lewis rats(2000)110 cited
- → Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis(2002)77 cited
- → Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis(2002)57 cited
- → Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis(2002)49 cited
- → Interleukin-1β and Tumor Necrosis Factor-α Produce Distinct, Time-dependent Patterns of Acute Arthritis in the Rat Knee(2004)24 cited
- → OP0016 Osteoclast numbers in joints of rats with adjuvant arthritis are decreased by treatment with il-1ra and/or peg stnf-ri(2001)3 cited
- → Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease(2001)3 cited
- → OP0061 Recombinant osteoprotegerin (opg) regulates bone erosions and osteoclast numbers in a schedule-dependent manner in joints of male lewis rats with adjuvant arthritis(2001)